Abstract 5843: The efficacy of a histone deacetylase inhibitor in combination with a MEK inhibitor in lung cancer cells harboring RAS mutations

2018 ◽  
Author(s):  
Tadaaki Yamada ◽  
Joseph M. Amann ◽  
Azusa Tanimoto ◽  
Hirokazu Taniguchi ◽  
Takehito Shukuya ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Mek Inhibitor ◽  
Lung Cancer Cells ◽  
Ras Mutations ◽  
Deacetylase Inhibitor

Abstract 5187: Effect of histone deacetylase inhibitor on PD-L1 expression in lung cancer cells

2019 ◽  
Author(s):  
Umamaheswari Natarajan ◽  
Thiagarajan Venkatesan ◽  
R Vijayaraghavan ◽  
Shila Samuel ◽  
Appu Rathinavelu
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Lung Cancer Cells ◽  
Deacetylase Inhibitor

scholarly journals Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations

2017 ◽  
Vol 17 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Tadaaki Yamada ◽  
Joseph M. Amann ◽  
Azusa Tanimoto ◽  
Hirokazu Taniguchi ◽  
Takehito Shukuya ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Antitumor Activity ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Mek Inhibitor ◽  
Lung Cancer Cells ◽  
Histone Deacetylase Inhibition ◽  
Ras Mutations

Abstract 5187: Effect of histone deacetylase inhibitor on PD-L1 expression in lung cancer cells

2019 ◽  
Author(s):  
Umamaheswari Natarajan ◽  
Thiagarajan Venkatesan ◽  
R Vijayaraghavan ◽  
Shila Samuel ◽  
Appu Rathinavelu
Keyword(s):  
Lung Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Lung Cancer Cells ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document